Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7338599

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of group
Business results of group
Net sales
180,870,000 JPY
1,625,889,000 JPY
226,967,000 JPY
Ordinary profit (loss)
-394,494,000 JPY
-1,126,283,000 JPY
-513,368,000 JPY
Profit (loss) attributable to owners of parent
-398,890,000 JPY
-1,152,895,000 JPY
-519,210,000 JPY
Comprehensive income
-359,563,000 JPY
-1,135,377,000 JPY
-518,278,000 JPY
Net assets
3,517,971,000 JPY
3,877,535,000 JPY
4,397,841,000 JPY
Total assets
3,894,220,000 JPY
4,349,891,000 JPY
4,945,261,000 JPY
Basic earnings (loss) per share
-23.27
-68.62
-32.78
Diluted earnings per share
Equity-to-asset ratio
0.903 xbrli:pure
0.891 xbrli:pure
0.888 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.